Wu, Fenfen <br/><br/>
Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.  [electronic resource] 

 -  Brain : a journal of neurology  Dec 2013 
 - 3766-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2156 
<br/><br/><label>Standard No.: </label>10.1093/brain/awt280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetazolamide--pharmacology<br/>Animals<br/>Arginine--genetics<br/>Bumetanide--therapeutic use<br/>Calcium Channels, L-Type--genetics<br/>Carbonic Anhydrase Inhibitors--pharmacology<br/>Disease Models, Animal<br/>Evoked Potentials, Motor--drug effects<br/>Furosemide--pharmacology<br/>Glucose--metabolism<br/>Histidine--genetics<br/>Hypokalemic Periodic Paralysis--drug therapy<br/>In Vitro Techniques<br/>Isometric Contraction--drug effects<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Muscle, Skeletal--physiopathology<br/>Mutation--genetics<br/>Sodium Potassium Chloride Symporter Inhibitors--therapeutic use